Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
CALL
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $1.71M | ﹤0.01% |
39,100
+29,100
| +291% | +$1.27M |
|
4502
PUT
Southern Copper
SCCO
$156B
| $1.7M | ﹤0.01% |
43,120
-11,245
| -21% | -$457K |
|
|
SVC
4503
CALL
Service Properties Trust
SVC
$1.05B
| $1.7M | ﹤0.01% |
11,820
+2,820
| +31% | +$404K |
|
4504
PUT
Jones Lang LaSalle
JLL
$17.3B
| $1.7M | ﹤0.01% |
11,800
+3,500
| +42% | +$550K |
|
|
CMD
4505
CALL
DELISTED
Cantel Medical Corporation
CMD
| $1.7M | ﹤0.01% |
18,500
+11,200
| +153% | +$1.07M |
|
|
CBM
4506
CALL
DELISTED
Cambrex Corporation
CBM
| $1.7M | ﹤0.01% |
+24,900
| New | +$1.54M |
|
|
HAO
4507
DELISTED
Invesco China Small Cap ETF
HAO
| $1.7M | ﹤0.01% |
+63,822
| New | +$1.76M |
|
4508
CALL
Scotiabank
BNS
$112B
| $1.7M | ﹤0.01% |
28,500
+17,300
| +154% | +$1.01M |
|
4509
PUT
Huntington Bancshares
HBAN
$36.2B
| $1.7M | ﹤0.01% |
113,900
-4,000
| -3% | -$62.5K |
|
4510
CALL
ProShares Ultra Semiconductors
USD
$2.96B
| $1.7M | ﹤0.01% |
604,800
-129,600
| -18% | -$364K |
|
4511
EXL Service
EXLS
$5.28B
| $1.7M | ﹤0.01% |
128,120
-2,050
| -2% | -$25.4K |
|
4512
PUT
Enanta Pharmaceuticals
ENTA
$383M
| $1.69M | ﹤0.01% |
19,800
+13,400
| +209% | +$1.34M |
|
|
IMPV
4513
CALL
DELISTED
Imperva, Inc.
IMPV
| $1.69M | ﹤0.01% |
36,400
+20,900
| +135% | +$1.01M |
|
4514
PUT
Agios Pharmaceuticals
AGIO
$2B
| $1.69M | ﹤0.01% |
21,900
+5,700
| +35% | +$459K |
|
|
MLNX
4515
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.69M | ﹤0.01% |
23,000
-24,900
| -52% | -$2M |
|
|
ECYT
4516
CALL
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.69M | ﹤0.01% |
95,100
+12,900
| +16% | +$221K |
|
4517
PUT
Regency Centers
REG
$14B
| $1.69M | ﹤0.01% |
26,100
+22,800
| +691% | +$1.45M |
|
4518
Brady Corp
BRC
$4.44B
| $1.69M | ﹤0.01% |
38,554
+10,436
| +37% | +$415K |
|
4519
PUT
OneMain Financial
OMF
$7.56B
| $1.69M | ﹤0.01% |
50,200
+6,400
| +15% | +$224K |
|
|
SFLY
4520
DELISTED
Shutterfly, Inc.
SFLY
| $1.69M | ﹤0.01% |
25,596
-56,210
| -69% | -$4.45M |
|
4521
CALL
Globus Medical
GMED
$11.5B
| $1.69M | ﹤0.01% |
29,700
+10,400
| +54% | +$547K |
|
4522
CALL
Pacira BioSciences
PCRX
$917M
| $1.69M | ﹤0.01% |
34,300
+400
| +1% | +$17.3K |
|
4523
iShares MBS ETF
MBB
$39.1B
| $1.68M | ﹤0.01% |
+16,296
| New | +$1.69M |
|
4524
CALL
Zillow
ZG
$7.91B
| $1.68M | ﹤0.01% |
38,100
+15,400
| +68% | +$806K |
|
|
JBTM
4525
JBT Marel
JBTM
$6.23B
| $1.68M | ﹤0.01% |
14,109
-11,427
| -45% | -$1.24M |
|
Similar funds
Citadel Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Citadel Advisors opened 1,427 new positions and closed 1,043 in Q3 2018.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.